Tenapanor Nears US Approval for Hyperphosphatemia in Dialysis Tenapanor Nears US Approval for Hyperphosphatemia in Dialysis

The FDA granted an appeal to an earlier decision, resetting tenapanor on a path toward approval for treating hyperphosphatemia in patients undergoing dialysis.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Nephrology News Source Type: news